Pune, India -- (SBWIRE) -- 05/06/2020 -- Infinium Global Research has recently published a global report on "Radiopharmaceuticals Market (Radioisotopes - Technetium-99, Thallium-201, Gallium-67, Iodine-123, Flourine-18, Rubidium-82, Yttrium-90, Lutetium-177, and Other Radioisotopes; End-users - Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, and Research Centers): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025." The global radiopharmaceuticals market is projected to grow at a CAGR of 8.5% over the forecast period of 2019-2025.

Ask for Sample Copy of Research Report with Table of Content @https://www.infiniumglobalresearch.com/reports/sample-request/13764

Rapidly Expanding Rates of Cancer Diseases are the Driving Factor for the Growth of the Market

The rapidly expanding rates of cancer and cardiovascular diseases are the primary driving factor for the growth of the radiopharmaceuticals market. In addition, the cancer rates could further increase by 50% to 15 million new cases in the year 2020, according to the World Cancer Report. Growth in cancer diagnostics and treatments have ignited the preference of doctors towards the utilization of radiopharmaceuticals.

Radiopharmaceuticals like F-18, samarium, and technetium, which contribute more than 75% to the PET-analysis showcase, are utilized as a part of imaging to analyze cancer and cardiac diseases. With the expanding frequency of cancer and cardiovascular infections, the interest for radiopharmaceuticals will likewise increase.

Furthermore, public-private partnerships are emerging for the modernization of the healthcare infrastructure owing to the high cost of nuclear medicine devices and budget constraints. This factor is also aiding the adoption of radiopharmaceuticals for several treatments. However, comparatively short life of radiopharmaceuticals coupled with high cost hampers the growth of the market. Moreover, the growing focus on targeted therapies and an increasing number of potential radioisotopes in the pipeline creates fruitful opportunities for the market players.

"We are Now Including the Impact Analysis of the COVID-19 on this Premium Report and the Forecast Period of this Report Shall be Revised to 2020-2026. The Section on the Impact of COVID-19 on Radiopharmaceuticals Market is Included in the Report for Free."

North America is Expected to Hold the Largest Share in the Global Radiopharmaceuticals Market

Among the regions, North America is expected to hold the largest share in the globalradiopharmaceuticals market. The U.S. radiopharmaceuticals market is estimated to be the largest market among the North American countries. The installation of new cyclotrons, an increase in the incidence of cancer and heart patients, and well-defined reimbursement policies from public and private health insurance firms fuel the growth of the radiopharmaceuticals market in the U.S. market.

In addition, according to the World Nuclear Association, U.S. based Coqui Pharmaceuticals signed a contract with Argentinian nuclear engineering company INVAP to build an open-pool reactor similar to Australia's Opal reactor in order to have better Mo-99 production facility at Alachua County, Florida. Europe is anticipated to hold the second-largest share owing to the growing prevalence of cancer and increasing reimbursement policies.

Get this Section as a Free Customization in the Report Along with 30% Discount on the Study: https://www.infiniumglobalresearch.com/reports/request-discount/13764

"We Have Decided to Extend Our Support to the Industry on Account of Corona Outbreak by Offering Flat Discount 30% on All Our Studies and Evaluation of the Market Dynamics in Radiopharmaceuticals Amidst COVID-19."

Radiopharmaceuticals Market Coverage

Chapter - 1    Preface

=> Report Description

=> Research Methods

=> Research Approaches

Chapter - 2    Executive Summary

=> Radiopharmaceuticals Market Highlights

=> Radiopharmaceuticals Market Projection

=> Radiopharmaceuticals Market Regional Highlights

Chapter - 3    Global Radiopharmaceuticals Market Overview

=> Introduction

=> Market Dynamics

=> Porter's Five Forces Analysis

=> IGR-Growth Matrix Analysis

=> Value Chain Analysis of Radiopharmaceuticals Market

Chapter - 4    Radiopharmaceuticals Market Macro Indicator Analysis

Chapter - 5    Global Radiopharmaceuticals Market by Radioisotopes

=> Technetium-99

=> Thallium-201

=> Gallium-67

=> Iodine-123

=> Flourine-18

=> Rubidium-82

=> Yttrium-90

=> Lutetium-177

=> Other Radioisotopes

Chapter - 6    Global Radiopharmaceuticals Market by End-users

=> Hospitals

=> Ambulatory Surgical Centers

=> Diagnostic Centers

=> Research Centers

Chapter - 7    Global Radiopharmaceuticals Market by Region 2019-2025

=> North America

=> Europe

=> Asia-Pacific

=> RoW

Chapter - 8    Company Profiles and Competitive Landscape

=> GE Healthcare

=> Cardinal Health, Inc.

=> Mallinckrodt Pharmaceuticals

=> Lantheus Medical Imaging, Inc.

=> Bayer AG

=> Advanced Accelerator Applications S.A.

=> Bracco Imaging S.p.A.

=> EczacibasiMonrol Nuclear Products Co.

=> Nordion Inc.

=> Urenco Group

Chapter - 9    Appendix

=> Primary Research Findings and Questionnaire

Browse Complete Report@ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-radiopharmaceuticals-market

About Infinium Global Research
Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes and non-profit/non-government organizations to meet their knowledge and information needs.

Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide the knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations and environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.